These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 17545193

  • 1. Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjögren syndrome: a randomised controlled trial.
    Hartkamp A, Geenen R, Godaert GL, Bootsma H, Kruize AA, Bijlsma JW, Derksen RH.
    Ann Rheum Dis; 2008 Jan; 67(1):91-7. PubMed ID: 17545193
    [Abstract] [Full Text] [Related]

  • 2. Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial.
    Hartkamp A, Geenen R, Godaert GL, Bijl M, Bijlsma JW, Derksen RH.
    Ann Rheum Dis; 2010 Jun; 69(6):1144-7. PubMed ID: 19854713
    [Abstract] [Full Text] [Related]

  • 3. Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study.
    Dass S, Bowman SJ, Vital EM, Ikeda K, Pease CT, Hamburger J, Richards A, Rauz S, Emery P.
    Ann Rheum Dis; 2008 Nov; 67(11):1541-4. PubMed ID: 18276741
    [Abstract] [Full Text] [Related]

  • 4. Dehydroepiandrosterone (DHEA) substitution treatment for severe fatigue in DHEA-deficient patients with primary Sjögren's syndrome.
    Virkki LM, Porola P, Forsblad-d'Elia H, Valtysdottir S, Solovieva SA, Konttinen YT.
    Arthritis Care Res (Hoboken); 2010 Jan 15; 62(1):118-24. PubMed ID: 20191499
    [Abstract] [Full Text] [Related]

  • 5. Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome.
    Pillemer SR, Brennan MT, Sankar V, Leakan RA, Smith JA, Grisius M, Ligier S, Radfar L, Kok MR, Kingman A, Fox PC.
    Arthritis Rheum; 2004 Aug 15; 51(4):601-4. PubMed ID: 15334433
    [Abstract] [Full Text] [Related]

  • 6. A randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia.
    Finckh A, Berner IC, Aubry-Rozier B, So AK.
    J Rheumatol; 2005 Jul 15; 32(7):1336-40. PubMed ID: 15996074
    [Abstract] [Full Text] [Related]

  • 7. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
    Ritsner MS, Gibel A, Ratner Y, Tsinovoy G, Strous RD.
    J Clin Psychopharmacol; 2006 Oct 15; 26(5):495-9. PubMed ID: 16974191
    [Abstract] [Full Text] [Related]

  • 8. Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).
    Mariette X, Ravaud P, Steinfeld S, Baron G, Goetz J, Hachulla E, Combe B, Puéchal X, Pennec Y, Sauvezie B, Perdriger A, Hayem G, Janin A, Sibilia J.
    Arthritis Rheum; 2004 Apr 15; 50(4):1270-6. PubMed ID: 15077311
    [Abstract] [Full Text] [Related]

  • 9. Quality of life and psychological status in patients with primary Sjögren's syndrome and sicca symptoms without autoimmune features.
    Champey J, Corruble E, Gottenberg JE, Buhl C, Meyer T, Caudmont C, Bergé E, Pellet J, Hardy P, Mariette X.
    Arthritis Rheum; 2006 Jun 15; 55(3):451-7. PubMed ID: 16739213
    [Abstract] [Full Text] [Related]

  • 10. Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations.
    Forsblad-d'Elia H, Carlsten H, Labrie F, Konttinen YT, Ohlsson C.
    J Clin Endocrinol Metab; 2009 Jun 15; 94(6):2044-51. PubMed ID: 19318446
    [Abstract] [Full Text] [Related]

  • 11. Low serum dehydroepiandrosterone sulfate in women with primary Sjögren's syndrome as an isolated sign of impaired HPA axis function.
    Valtysdóttir ST, Wide L, Hällgren R.
    J Rheumatol; 2001 Jun 15; 28(6):1259-65. PubMed ID: 11409117
    [Abstract] [Full Text] [Related]

  • 12. Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus.
    Nordmark G, Bengtsson C, Larsson A, Karlsson FA, Sturfelt G, Rönnblom L.
    Autoimmunity; 2005 Nov 15; 38(7):531-40. PubMed ID: 16373258
    [Abstract] [Full Text] [Related]

  • 13. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial.
    Chang DM, Lan JL, Lin HY, Luo SF.
    Arthritis Rheum; 2002 Nov 15; 46(11):2924-7. PubMed ID: 12428233
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial.
    Meijer JM, Meiners PM, Vissink A, Spijkervet FK, Abdulahad W, Kamminga N, Brouwer E, Kallenberg CG, Bootsma H.
    Arthritis Rheum; 2010 Apr 15; 62(4):960-8. PubMed ID: 20131246
    [Abstract] [Full Text] [Related]

  • 15. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
    Khurshudian AV.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan 15; 95(1):38-44. PubMed ID: 12539025
    [Abstract] [Full Text] [Related]

  • 16. Failure of oral DHEA treatment to increase local salivary androgen outputs of female patients with Sjögren's syndrome.
    Porola P, Straub RH, Virkki LM, Konttinen YT, Nordström DC.
    Scand J Rheumatol; 2011 Jan 15; 40(5):387-90. PubMed ID: 21877998
    [Abstract] [Full Text] [Related]

  • 17. Sex steroid hormones in primary Sjögren's syndrome.
    Brennan MT, Sankar V, Leakan RA, Grisius MM, Collins MT, Fox PC, Baum BJ, Pillemer SR.
    J Rheumatol; 2003 Jun 15; 30(6):1267-71. PubMed ID: 12784401
    [Abstract] [Full Text] [Related]

  • 18. Psychological and somatic predictors of perceived and measured ocular dryness of patients with primary Sjögren's syndrome.
    Vriezekolk JE, Geenen R, Hartkamp A, Godaert GL, Bootsma H, Kruize AA, Bijlsma JW, Derksen RH.
    J Rheumatol; 2005 Dec 15; 32(12):2351-5. PubMed ID: 16331762
    [Abstract] [Full Text] [Related]

  • 19. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial.
    Hunt PJ, Gurnell EM, Huppert FA, Richards C, Prevost AT, Wass JA, Herbert J, Chatterjee VK.
    J Clin Endocrinol Metab; 2000 Dec 15; 85(12):4650-6. PubMed ID: 11134123
    [Abstract] [Full Text] [Related]

  • 20. Mental wellbeing and quality of sexual life in women with primary Sjögren's syndrome are related to circulating dehydroepiandrosterone sulphate.
    Valtysdottir ST, Wide L, Hallgren R.
    Ann Rheum Dis; 2003 Sep 15; 62(9):875-9. PubMed ID: 12922962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.